Durham’s Mycovia Pharma receives plenty of ‘buzz’ for global bio investor forum
Durham’s Mycovia Pharmaceuticals has emerged as the winner over nine finalist life science startups from across the nation vying for recognition in the “Buzz of BIO” Late Stage Leaders competition, part of the BIO Investor Forum taking place in San Francisco in October.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed